English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 864756      Online Users : 345
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Community Statistics


    近3年內發表的文件:335(13.91%)
    含全文筆數:2250(93.40%)

    文件下載次數統計
    下載大於0次:2250(100.00%)
    下載大於100次:2250(100.00%)
    檔案下載總次數:1611277(30.06%)

    最後更新時間: 2024-11-28 18:37

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 701-725 of 2409. (97 Page(s) Totally)
    << < 24 25 26 27 28 29 30 31 32 33 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2019-02 NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors European Journal of Cancer. 2019 Feb;108:78-87.
    2019-02 Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 269.
    2019-02 A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naive, advanced, or metastatic biliary tract cancer (BTC) Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 319.
    2019-02 Evaluation of efficacy of nivolumab by baseline factors from ATTRACTION-2 Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 8.
    2019-02 A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number TPS468.
    2019-01-15 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
    2019-01-09 Novel STAT3 inhibitor LDOC1 targets phospho-JAK2 for degradation by interacting with LNX1 and regulates the aggressiveness of lung cancer Cancers. 2019 Jan 9;11(1):Article number 63.
    2019-01-03 KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC Oncogene. 2019 Jan 3;38(1):17-32.
    2019-01-02 FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer Journal of Clinical Medicine. 2019 Jan 2;8(1):Article number 38.
    2019-01 Inhibition of the formation of autophagosome but not autolysosome augments ABT-751-induced apoptosis in TP53-deficient Hep-3B cells Journal of Cellular Physiology. 2019 Jan;234(6):9551-9563.
    2019-01 Identification of the novel role of CD24 as an oncogenesis regulator and therapeutic target for triple negative breast cancer Molecular Cancer Therapeutics. 2019 Jan;18(1):147-161.
    2019-01 Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin European Journal of Cancer. 2019 Jan;106:24-33.
    2019-01 Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Annals of Oncology. 2019 Jan;30(1):19-33.
    2019-01 Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Annals of Oncology. 2019 Jan;30(1):34-43.
    2019-01 Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression Oncology Letters. 2019 Jan;17(2):1551-1558.
    2019-01 Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer Theranostics. 2019 Jan;9(2):324-336.
    2018-12-22 Osteopontin-integrin engagement induces HIF-1α-TCF12- mediated endothelial-mesenchymal transition to exacerbate colorectal cancer Oncotarget. 2018 Dec 22;9(4):4998-5015.
    2018-12-20 Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression Cancers. 2018 Dec 20;11(1):Article number 8.
    2018-12-06 USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation Oncogene. 2018 Dec 6;37(49):6327-6340.
    2018-12 Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells Biochemical Pharmacology. 2018 Dec;158:327-338.
    2018-12 Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines Cancer Science. 2018 Dec;109(Suppl. 2):386.
    2018-12 Lon-ROS axis induces mtDNA release that activate cGAS-STING-IFN signaling and pack in exosome in tumor microenvironment Cancer Science. 2018 Dec;109(Suppl. 2):1227.
    2018-12 p53 is sequestered by mitochondrial chaperone Lon in the matrix to restrain apoptosis under oxidative stress Cancer Science. 2018 Dec;109(Suppl. 2):1293.
    2018-12 c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation Cancer Science. 2018 Dec;109(Suppl. 2):866.
    2018-12 NNK induces miR-944 expression and modulates CISH/STAT3 signaling pathway in oral squamous cell carcinoma Cancer Science. 2018 Dec;109(Suppl. 2):391.

    Showing items 701-725 of 2409. (97 Page(s) Totally)
    << < 24 25 26 27 28 29 30 31 32 33 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback